Physician

John Stuart Walsh, M.D.

According to 2025 Medicare claims, John Walsh, M.D. (NPI: 1942298161) practices dermatology in the Seattle-Bellevue-Kent, WA market, with the plurality of this provider's patient population coming from King, WA. This provider's primary affiliated billing organization is DERMATOPATHOLOTY NORTHWEST PLLC (NPI: 1932296092; TIN: 912006337) and primary practice location at 98005-1756.

Walsh's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 6,502 traditional Medicare patients, billed 12,621 HCPCS/CPT codes, and received $658,905 in Medicare payments. The top billing code was 88342 (Special stained specimen slides to examine tissue, initial procedure). Part D data shows 35 prescription claims across 14 beneficiaries totaling $726 in drug costs. Open Payments data shows 1 records totaling $30. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs started with an early spike, then settled into a lower baseline, moving from $48,276 to $726. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$409K$818K2015 Medicare payment: $459,202 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $697,075 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $691,111 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $684,945 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $724,124 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $674,442 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $742,989 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $818,445 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $779,520 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $658,905 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20155,1299,847$459,202
20168,17315,927$697,075
20179,22417,978$691,111
20189,36317,603$684,945
20199,08917,015$724,124
20208,13115,435$674,442
20218,57115,765$742,989
20229,46617,565$818,445
20238,48316,041$779,520
20246,50212,621$658,905

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$24K$48K2015 Drug cost: $48,276 (USD; Tot_Drug_Cst)2016 Drug cost: $20,383 (USD; Tot_Drug_Cst)2017 Drug cost: $34,704 (USD; Tot_Drug_Cst)2018 Drug cost: $12,158 (USD; Tot_Drug_Cst)2019 Drug cost: $10,573 (USD; Tot_Drug_Cst)2020 Drug cost: $7,808 (USD; Tot_Drug_Cst)2021 Drug cost: $28,870 (USD; Tot_Drug_Cst)2022 Drug cost: $1,692 (USD; Tot_Drug_Cst)2023 Drug cost: $1,658 (USD; Tot_Drug_Cst)2024 Drug cost: $726 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
201549111$48,276
201669129$20,383
201763186$34,704
201855123$12,158
201958112$10,573
20203276$7,808
20214589$28,870
20223554$1,692
20233151$1,658
20241435$726

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
88342Special stained specimen slides to examine tissue, initial procedure644781$93
88321Surgical pathology consultation and report on referred slides prepared elsewhere120127$82
88341Special stained specimen slides to examine tissue, each additional procedure381656$80
88305Pathology examination of tissue using a microscope, intermediate complexity6,33710,557$47
88304Pathology examination of tissue using a microscope, moderately low complexity147159$33

Top 5 Part D drugs in 2024

By total drug costs.

Part D summary data is connected for 2024, but public drug-level costs are not available, so a Top 5 by total drug costs cannot be shown.

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.1$30ABBVIE INC.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for John Stuart Walsh, M.D.?

Tedicare shows public-source Medicare data for John Stuart Walsh, M.D. (NPI 1942298161), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does John Stuart Walsh, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to John Stuart Walsh, M.D.?

John Stuart Walsh, M.D. is linked to DERMATOPATHOLOTY NORTHWEST PLLC (billing NPI 1932296092) in the available physician profile data.

Does John Stuart Walsh, M.D. have Open Payments data?

John Stuart Walsh, M.D. has 1 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.